FY17 ARP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) Research and Development Directorate (J9) manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

Clinical Trial Award – Preapplication due July 2, 2017

Investigators at or above the level of Associate Professor (or equivalent), or

• ·         Early-Career Investigator Option:
  Investigators at or above the level of Associate Professor (or equivalent) may collaborate on a single application with a Early-Career Investigator (at the level of postdoctoral fellow up to early-career independent faculty) that meets the following criteria at the application submission deadline date:
• o    Must be within the first year of postdoctoral fellowship by the application deadline
• o    Is no more than 7 years from the receipt of a terminal degree
• o    Has the freedom to commit at least 50% time to the project
• ·         Supports research with the potential to have a major impact on the treatment and/or management of autism spectrum disorder (ASD).
• ·         Applications in the following areas are strongly encouraged:
• o    Behavioral, cognitive, and other non-pharmacological therapies.  Studies targeting subgroups using biomarkers with preliminary data are strongly encouraged.
• o    Pharmacological treatments in ASD. Studies targeting subgroups using biomarkers with preliminary data are strongly encouraged.
• o    Dissemination/implementation of clinically validated interventions across the lifespan.
• o    Therapies to alleviate conditions co-occurring with ASD.
• o    Interventions promoting success in ley transitions to adulthood for individuals living with ASD.
• o    Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD, particularly adulthood.

• Preliminary data relevant to the proposed project are required.
• Pre-application is required; application submission is by invitation only.

 

• ·         Nested Early-Career Investigator Option supports the development of young investigators pursuing or wishing to pursue clinical trials.

• Maximum funding of $1,000,000 for direct costs (plus indirect costs)
• Maximum period of performance is 4 years

 

• ·         Nested Yearly-Career  Investigator Option:

• Maximum funding of $1,300,000 for direct costs (plus indirect costs)

• ·         Maximum period of performance is 4 years

 

Idea Development Award – Preapplication due July 26, 2017

Investigators at or above the level of Assistant Professor (or equivalent)

• ·         Supports the development of innovation, high-impact ideas that advance the understanding of ASD and ultimately lead to improved outcomes.
• ·         Applications in the following areas are strongly encouraged:
• o    Assessment of novel therapeutics using valid preclinical models.
• o    Environmental risk factors.
• o    Mechanisms of heterogeneous clinical expression of ASD.
• o    Factors promoting success in key transitions to independence for individuals living with ASD.
• o    Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD, particularly in adulthood.
• o    Cultural factors in treatment efficacy, delivery, and access to services.

• Preliminary data are required.

• ·         Pre-application is required; application submission is by invitation only.

• Multiple Principal Investigator (PI) Option: Up to two investigators may collaborate on a single application, each of whom will be recognized as a PI and receive a separate award.
• Maximum allowable funding for the entire period of performance is of $500,000 in direct costs
• For multiple PI’s the combined funding for all PIs for the entire period of performance may not exceed $500,000 in direct costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• Maximum period of performance is 3 years

 

Clinical Translational Research Award – Preapplication due July 26, 2017

Investigators at or above the level of Assistant Professor (or equivalent)

• Supports early-phase, proof-of-principle translational studies with the potential to have a major impact on the treatment and/or management of ASD.
• Applications in the following areas are strongly encouraged:
• • Behavioral, cognitive, and other non-pharmacological therapies.  Studies targeting subgroups using biomarkers with preliminary date are strongly encouraged.
  • Pharmacological treatments in ASD.  Studies targeting subgroups using biomarkers with preliminary data are strongly encouraged.
  • Dissemination/implementation of clinically validated interventions across the lifespan.
  • Therapies to alleviate conditions co-occurring with ASD.
  • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD, particularly in adulthood.
• Preliminary data relevant to the proposed project are required.

• ·         Pre-application is required; application submission is by invitation only.

• The maximum allowable funding for the entire period of performance is $500,000 in direct costs
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

• ·         Maximum period of performance is 3 years

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Grants.gov. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the ARP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507

help@eBrap.org